MIRA Pharmaceuticals Announces Promising Preclinical Results for SKNY-1 Oral Obesity and Addiction Drug Candidate with Robust Brain Penetration and Once-Daily Dosing Potential 13
MIRA Pharmaceuticals Reports Successful Preclinical Results ...
Sign in to continue:
MIRA Pharmaceuticals Reports Successful Preclinical Results ...
Volato Group, Inc. Reports Record Q2 2026 Results, Advances ...
Capstone Holding Corp. Announces Amendment to \$20 Million C...
Tutor Perini Corporation Announces Issuance of \$400 Million...
Neolara Corp. Announces Potential Entry into AI-Driven Image...
Moog Inc. Elects Carl R. Christenson to Board of Directors –...
Solstice Advanced Materials to Acquire Element Solutions in ...
Liminatus Pharma, Inc. Announces Amended and Restated Merger...
Kartoon Studios, Inc. Issues Amendment to Rights Agreement: ...
Solstice Advanced Materials to Acquire Element Solutions: Ma...